Уважаемые коллеги, доброго времени суток! Представляем вам британское научное издание Critical Care Nursing Clinics of North America. Журнал имеет третий квартиль, издаётся в W.B. Saunders Ltd., его SJR за 2022 г. равен 0,366, печатный ISSN - 0899-5885, электронный - 1558-3481, предметная область Уход за больными в реанимации. Вот так выглядит обложка:
Редактором является Жан Фостер, контактные данные - jan.foster@ngu.edu.
Являясь ведущим источником консультаций для медсестер отделения интенсивной терапии в больнице, Critical Care Nursing Clinics of North America предоставляет ответы на клинические вопросы, обновленную информацию о последних достижениях для улучшения результатов лечения пациентов, многочисленные клинические изображения и рекомендации по уходу за пациентами. Предлагая широкий спектр информации о практике сестринского дела в критических и неотложных состояниях, каждый выпуск данной ежеквартальной серии позволяет медсестрам более эффективно ухаживать за пациентами и их семьями.
Адрес издания - https://www.ccnursing.theclinics.com/
Пример статьи, название - Intravenous Smart Pumps. Заголовок (Introduction) - Intravenous (IV) infusion pump systems are among the most frequently used technologies in health care. An estimated 90% of hospital patients receive IV medications via infusion pumps, an indication of how pervasive these devices are in patient care, particularly in critical and acute care settings. Clinical use of IV smart pumps with built-in dose error reduction systems (DERS) began at Massachusetts General Hospital in 1996 and has since become widely accepted as a standard of care for the reduction of infusion-related medication error. A 2012 national survey by the American Society of Healthcare System Pharmacists found a 77% adoption rate of IV Smart pumps by US hospitals. Although the use of IV smart pumps has been associated with decreases in medication error rates, they have not eliminated error. Furthermore, current data do not support that the use of IV smart pumps has had a measurable impact on decreasing adverse drug events (ADEs). A recent review of the US Food and Drug Administration (FDA) Manufacturer and User Device Experience database for 2015 to 2017 revealed more than 23,000 submitted reports of malfunction and injury for the 3 most commonly used large volume IV smart pumps (Alaris, Baxter, and Hospira).Common sources of user error include overriding dose error alerts and, even more concerning, manually bypassing the drug libraries and DERS completely. The complexity of the device user interface, the time required to program the DERS, and incomplete drug libraries are among the most frequently cited reasons that nurses bypass IV smart pump safety features.11The complexity of IV medication administration and the multiple steps involved demands close attention to detail and ultimately relies heavily on human–device interaction to detect and mitigate errors. Clinicians in the busy critical care and medical-surgical clinical environments are frequently interrupted and rushed during IV smart pump programming. As a result, the overriding of alerts and programming outside of the DERS owing to time constraints and competing work demands are recognized as a part of daily clinical practice. Despite an increasing focus in health care on patient safety and quality of care, and despite improvements in technology, medication errors and usability issues with IV smart pumps are a significant patient safety issue. In 2015, Association for the Advancement of Medical Instrumentation initiated a multiyear national coalition to address IV infusion device safety.The ubiquity of IV smart pumps, along with a sense of urgency to address IV medication safety, has garnered the attention of several organizations focused on patient safety. The Association for the Advancement of Medical Instrumentation (AAMI) and the FDA cosponsored a summit in 2010 to prioritize patient safety related to IV infusions as a national concern. In 2012, the National Quality Forum conducted an environmental analysis that resulted in 13 recommendations to improve safety of IV infusion devices. The 2014 Emergency Care Research Institute identified alarm hazards and infusion pump medication errors as priorities that need immediate attention.
